GSTM1 and nutritional disorder: In this study, we showed that the treatment with FCM in cancer patients undergoing chemotherapy (with a grade ≥2 anaemia and iron deficiency) was effective in 85% of cases, improving the mean Hb levels of anaemic cancer patients.